First Alzheimer's Drug in 20 Years Slows Disease

After two decades of setbacks, scientists have achieved a major breakthrough with Lecanemab, the first fully approved treatment that actually slows Alzheimer's progression.

Over 200 more potential treatments are now racing through clinical trials, bringing real hope to millions of families.